Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Neuroendocrine Carcinoma|Breast Cancer|Ovarian Cancer
Interventions: DRUG: Injection of 68Ga-NODAGA-E(c[RGDyK])2
Sponsor: Rigshospitalet, Denmark